70 related articles for article (PubMed ID: 25746036)
1. TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases.
Jangard M; Zebary A; Ragnarsson-Olding B; Hansson J
Melanoma Res; 2015 Jun; 25(3):185-8. PubMed ID: 25746036
[TBL] [Abstract][Full Text] [Related]
2. Mutation status among patients with sinonasal mucosal melanoma and its impact on survival.
Amit M; Tam S; Abdelmeguid AS; Roberts DB; Takahashi Y; Raza SM; Su SY; Kupferman ME; DeMonte F; Hanna EY
Br J Cancer; 2017 Jun; 116(12):1564-1571. PubMed ID: 28494469
[TBL] [Abstract][Full Text] [Related]
3. Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis.
Thomas NE; Edmiston SN; Tsai YS; Parker JS; Googe PB; Busam KJ; Scott GA; Zedek DC; Parrish EA; Hao H; Slater NA; Pearlstein MV; Frank JS; Kuan PF; Ollila DW; Conway K
Am J Dermatopathol; 2019 Apr; 41(4):264-272. PubMed ID: 30211730
[TBL] [Abstract][Full Text] [Related]
4. Sinonasal Mucosal Melanoma: An Update and Review of the Literature.
Salari B; Foreman RK; Emerick KS; Lawrence DP; Duncan LM
Am J Dermatopathol; 2022 Jun; 44(6):424-432. PubMed ID: 35315370
[TBL] [Abstract][Full Text] [Related]
5. Germline TERT promoter mutations are rare in familial melanoma.
Harland M; Petljak M; Robles-Espinoza CD; Ding Z; Gruis NA; van Doorn R; Pooley KA; Dunning AM; Aoude LG; Wadt KA; Gerdes AM; Brown KM; Hayward NK; Newton-Bishop JA; Adams DJ; Bishop DT
Fam Cancer; 2016 Jan; 15(1):139-44. PubMed ID: 26433962
[TBL] [Abstract][Full Text] [Related]
6. Highly recurrent TERT promoter mutations in human melanoma.
Huang FW; Hodis E; Xu MJ; Kryukov GV; Chin L; Garraway LA
Science; 2013 Feb; 339(6122):957-9. PubMed ID: 23348506
[TBL] [Abstract][Full Text] [Related]
7. Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort.
Chang GA; Robinson E; Wiggins JM; Zhang Y; Tadepalli JS; Schafer CN; Darvishian F; Berman RS; Shapiro R; Shao Y; Osman I; Polsky D
J Invest Dermatol; 2022 Oct; 142(10):2733-2743.e9. PubMed ID: 35469904
[TBL] [Abstract][Full Text] [Related]
8. TERT promoter mutations in atypical melanocytic lesions: A series of seven cases with adverse melanoma-specific outcome.
Huber R; Lee J; Borretta L; Tessier-Cloutier B; Lum A; Yip S; Horst BA
Hum Pathol; 2024 Feb; 144():34-39. PubMed ID: 38224873
[TBL] [Abstract][Full Text] [Related]
9. TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type.
El Zarif T; Machaalani M; Nawfal R; Nassar AH; Xie W; Choueiri TK; Pomerantz M
Oncologist; 2024 Jan; 29(1):8-14. PubMed ID: 37462445
[TBL] [Abstract][Full Text] [Related]
10. TERT expression is associated with metastasis from thin primaries, exhausted CD4+ T cells in melanoma and with DNA repair across cancer entities.
Kuhn CK; Meister J; Kreft S; Stiller M; Puppel SH; Zaremba A; Scheffler B; Ullrich V; Schöneberg T; Schadendorf D; Horn S
PLoS One; 2023; 18(7):e0281487. PubMed ID: 37418389
[TBL] [Abstract][Full Text] [Related]
11. Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center study.
Scherzad A; Stöth M; Meyer TJ; Haug L; Gehrke T; Schilling B; Meierjohann S; Scheich M; Hagen R; Gesierich A; Hackenberg S
Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4215-4223. PubMed ID: 37272953
[TBL] [Abstract][Full Text] [Related]
12. Detecting recurrent passenger mutations in melanoma by targeted UV damage sequencing.
Selvam K; Sivapragasam S; Poon GMK; Wyrick JJ
Nat Commun; 2023 May; 14(1):2702. PubMed ID: 37169747
[TBL] [Abstract][Full Text] [Related]
13. Nuclear-specific accumulation of
Hellgren LS; Olsson A; Kaufeldt A; Paulsson JO; Hysek M; Stenman A; Zedenius J; Larsson C; Höög A; Juhlin CC
J Clin Pathol; 2021 May; 75(10):658-62. PubMed ID: 34011619
[TBL] [Abstract][Full Text] [Related]
14. Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross-sectional study in 684 melanoma patients.
Manrique-Silva E; David ME; Maider AM; García-Casado Z; Moro R; Requena C; Través V; Virós A; Kumar R; Nagore E
Pigment Cell Melanoma Res; 2024 May; 37(3):343-351. PubMed ID: 38153178
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of recurrent CDC20 promoter variants in human melanoma.
Godoy PM; Oyedeji A; Mudd JL; Morikis VA; Zarov AP; Longmore GD; Fields RC; Kaufman CK
Commun Biol; 2023 Nov; 6(1):1216. PubMed ID: 38030698
[TBL] [Abstract][Full Text] [Related]
16. RE: TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
Pópulo H; Lopes JM; Sobrinho-Simões M; Soares P
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25755155
[No Abstract] [Full Text] [Related]
17. TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.
Heidenreich B; Rachakonda PS; Hosen I; Volz F; Hemminki K; Weyerbrock A; Kumar R
Oncotarget; 2015 Apr; 6(12):10617-33. PubMed ID: 25797251
[TBL] [Abstract][Full Text] [Related]
18. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.
Weller M; Weber RG; Willscher E; Riehmer V; Hentschel B; Kreuz M; Felsberg J; Beyer U; Löffler-Wirth H; Kaulich K; Steinbach JP; Hartmann C; Gramatzki D; Schramm J; Westphal M; Schackert G; Simon M; Martens T; Boström J; Hagel C; Sabel M; Krex D; Tonn JC; Wick W; Noell S; Schlegel U; Radlwimmer B; Pietsch T; Loeffler M; von Deimling A; Binder H; Reifenberger G
Acta Neuropathol; 2015 May; 129(5):679-93. PubMed ID: 25783747
[TBL] [Abstract][Full Text] [Related]
19. Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Hosen I; Rachakonda PS; Heidenreich B; de Verdier PJ; Ryk C; Steineck G; Hemminki K; Kumar R
Int J Cancer; 2015 Oct; 137(7):1621-9. PubMed ID: 25809917
[TBL] [Abstract][Full Text] [Related]
20. TERT promoter mutations are rare in parathyroid tumors.
Haglund F; Juhlin CC; Brown T; Ghaderi M; Liu T; Stenman A; Dinets A; Prasad M; Korah R; Xu D; Carling T; Larsson C
Endocr Relat Cancer; 2015 Jun; 22(3):L9-L11. PubMed ID: 25876648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
